Friday, March 06, 2015

Lilly loses to Actavis over Alimta in Germany

Reuters reported on March 6:


Eli Lilly has lost a patent case in Germany over its blockbuster Alimta lung cancer drug to generic producer Actavis, hitting the U.S. drugmaker's future sales hopes for the medicine.


Post a Comment

<< Home